Search Result "rucaparib"
PARP Inhibitors in Ovarian Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 4 Year: 2018 Page: 392-410
Author(s): Gloria Mittica,Eleonora Ghisoni,Gaia Giannone,Sofia Genta,Massimo Aglietta,Anna Sapino,Giorgio Valabrega
Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 16 Issue: 2 Year: 2018 Page: 108-117
Author(s): Wei-Hua Shao,Lei-Yun Wang,Ji-Ye Yin
A Review on Poly (ADP-ribose) Polymerase (PARP) Inhibitors and Synthetic Methodologies
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 8 Year: 2021 Page: 1565-1584
Author(s): Ying Li,Chen-Fu Liu,Guo-Wu Rao
RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARPInhibitors
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 11 Year: 2023 Page: 900-909
Author(s): CÃntia Regina Niederauer Ramos,Renato José Silva Oliveira,Marcela Nunes Rosa,Ariane Stéfani Pereira,Renata Barbosa Vahia de Abreu,Andre van Helvoort Lengert,Rui Manuel Reis,Viviane Aline Oliveira Silva,Edenir Inêz Palmero,Matias Eliseo Melendez
Recent Development and Future Prospects of Molecular TargetedTherapy in Prostate Cancer
Journal: Current Molecular Pharmacology
Volume: 15 Issue: 1 Year: 2022 Page: 159-169
Author(s): Jinku Zhang,Jirui Sun,Sahar Bakht,Waseem Hassan
Kinase Phosphorylation-based Mechanisms of PARP Inhibitor Resistance During Synthetic Lethal Oncotherapy
Journal: Current Signal Transduction Therapy
Volume: 15 Issue: 1 Year: 2020 Page: 12-23
Author(s): Eriko Osaki,Shinya Mizuno
Hetero Cyclic Compounds in the Treatment of Triple-Negative BreastCancer
Journal: Current Cancer Therapy Reviews
Volume: 19 Issue: 3 Year: 2023 Page: 237-259
Author(s): Sudip Kumar Mandal,Biplab Kumar Dey,Santosh Kumar Rath
Clinical Trials of Poly(ADP-Ribose) Polymerase Inhibitors for Cancer Therapy: A Review
Journal: Reviews on Recent Clinical Trials
Volume: 10 Issue: 4 Year: 2015 Page: 326-339
Author(s): Michael Buege, Pramod B. Mahajan
Efficacy and Safety of PARP Inhibitor Therapy in Advanced OvarianCancer: A Systematic Review and Network Meta-analysis of RandomizedControlled Trials
Journal: Current Computer-Aided Drug Design
Volume: 20 Issue: 6 Year: 2024 Page: 736-751
Author(s):
Retrometabolic Approach for Designing Personalized Anti- Cancer Drug Molecules for Controlling Breast Cancer Resulted by BRCA1 Mutations
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 14 Issue: 1 Year: 2016 Page: 56-64
Author(s): Preethi M. Iyer,Sanjay K. Palayat,Karthikeyan Shanmugam,Krishnan Namboori